Breath Analysis News and Research

RSS

Bedfont® Scientific Limited recognized among Investec’s selected investments for 2025

Bedfont®, a world leader in breath analysis, has been recognized as one of Investec Direct Lending’s selected investments for 2025 following Keensight Capital’s majority investment in the company.

From Bedfont® Scientific Ltd 27 Aug 2026

Bedfont® brings respiratory monitoring solutions to ERS with a focus on clinical research

Bedfont® Scientific Limited, a world leader in breath analysis, is excited to be attending this year's European Respiratory Society (ERS) Congress in Barcelona.

From NObreath 12 Aug 2026

Asthma care is evolving. How FeNO testing is changing the way we treat asthma

Bedfont® Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath®, welcomes the news that over 1 million people with asthma are now using combination inhalers following the joint 2024 asthma guidelines from the National Institute for Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN).

From NObreath 8 Jul 2026

Bedfont® Scientific targets international growth at EAACI Congress 2026

Bedfont® Scientific Ltd., an innovative leader in the medical breath analysis industry with almost 50 years of experience, is pleased to join thousands of healthcare experts at this year’s European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026 at stand I03 to showcase its NObreath® and Gastrolyzer® range of non-invasive breath analysis devices.

From NObreath 20 May 2026

Bedfont® Scientific recognized for global growth with SEHTA Awards export shortlist

Bedfont® Scientific Limited, an innovative MedTech company that specialises in designing and manufacturing medical breath analysis devices, is thrilled to have been shortlisted in the Export Achievement category at the Science and Engineering Health Technologies Alliance (SEHTA) Healthcare Business Awards 2026.

From Bedfont® Scientific Ltd 12 May 2026

Shaping the future of asthma management with the NObreath® at ATS 2026

World leaders in breath analysis Bedfont® Scientific Ltd. are pleased to be attending this years American Thoracic Society (ATS) International Conference, to exhibit the innovative NObreath® Fractional exhaled Nitric Oxide (FeNO) device at booth 1236 alongside its US distributor coVita™.

From Bedfont® Scientific Ltd 11 May 2026

Bedfont® becomes the first compassionate workplace accredited in Kent

Bedfont® Scientific Ltd. is a world leader in breath analysis, with over 49 years of expertise in designing and manufacturing medical devices.

From Bedfont® Scientific Ltd 2 Apr 2026

Championing innovation: Bedfont® Scientific CTO shortlisted for Technology Leader of the Year

Scott Deamer-Smith, Chief Technology Officer (CTO) at Bedfont® Scientific Limited, has been recognized for his outstanding contribution to innovation and technology.

From Bedfont® Scientific Ltd 26 Mar 2026

Bedfont® Scientific Limited strengthens its position as world leaders in breath analysis with a new board member

Bedfont® Scientific Ltd., a world leader in breath analysis, has been designing and manufacturing medical breath analysis devices for almost 50 years and has seen significant growth over the past decade.

From Bedfont® Scientific Ltd 17 Mar 2026

Study on inhaler overuse highlights urgent need for better objective asthma monitoring

Bedfont® Scientific Limited, an innovative med-tech company specializing in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring whether enhanced asthma check-ups can reduce inhaler use among children.

From NObreath 11 Mar 2026

Giving opportunity, gaining innovation: Women driving the future of Med-Tech

Bedfont® Scientific Limited, a well-established Med-Tech company with over 49 years of expertise in the design and manufacture of medical breath analysis devices, is celebrating the women driving innovation in the Med-Tech industry this International Women’s Day (IWD).

From Bedfont® Scientific Ltd 3 Mar 2026

Bedfont® Scientific Limited partners with Rymindr to deliver vital classroom supplies

Bedfont® Scientific Limited, a world leader in breath analysis, with nearly 50 years of expertise in the medical device industry, has teamed up with Rymindr, a social-tech company, to deliver vital classroom supplies. Rymindr is an app that lets users track important dates and access rewards.

From Bedfont® Scientific Ltd 10 Feb 2026

coVita™ and Allergy Partners team up to improve asthma care in America

coVita™ LLC, a leader in advanced breath analysis and diagnostic solutions, serves as the U.S. distributor for the innovative NObreath® Fractional Exhaled Nitric Oxide (FeNO) device from UK-based Bedfont® Scientific Ltd.

From Bedfont® Scientific Ltd 13 Jan 2026

Bedfont® Scientific Limited is proud to exhibit cutting-edge breath analysis devices at WHX Dubai

Bedfont® Scientific, world leaders in breath analysis, with over 49 years of experience in the medical breath analysis industry, is thrilled to be showing its innovative devices at this year’s World Health Expo (WHX) Dubai, from the 9th to the 12th February 2026.

From Bedfont® Scientific Ltd 6 Jan 2026

Life-saving Christmas present arrives early at Medway United FC

Bedfont® Scientific Limited, an innovative MedTech company with over 49 years of experience in breath analysis, has proudly donated a defibrillator to Medway United FC.

From Bedfont® Scientific Ltd 16 Dec 2025

Noninvasive Raman device tracks blood glucose accurately in under a minute

MIT researchers developed a compact band-pass Raman spectroscopy device that noninvasively tracks glucose through the skin in under a minute using physically interpretable optical signals. In a pilot study and tissue phantom validation, the system showed glucose measurements comparable to commercial continuous glucose monitors, supporting further clinical evaluation.

7 Dec 2025

Bedfont® Scientific Limited expands global access to FeNO testing in India

Bedfont® Scientific Limited, world leaders in breath analysis, with over 48 years of experience in designing and manufacturing medical breath analysis devices, has collaborated with Rbeck Healtech Private to make Fractional exhaled Nitric Oxide (FeNO) testing more accessible in India.

From NObreath 1 Dec 2025

New AI tools offer hope for global TB elimination

Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could transform how tuberculosis is detected, monitored and prevented.

1 Dec 2025

Bedfont® Scientific Limited and Aerosol Medical Systems partner, expanding access to FeNO testing in Latin America

Bedfont® Scientific Limited, a world leader in breath analysis with nearly 50 years of expertise in the medical breath analysis industry, has formed a strategic partnership with Aerosol Medical Systems to improve Fractional exhaled Nitric Oxide (FeNO) testing accessibility in Latin America.

From NObreath 4 Nov 2025

OMED Health partners with Aviva to support the digestive health of employees

OMED Health ("OMED"), a UK-based business pioneering non-invasive breath analysis for gut health and part of Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced a pilot as part of its longstanding collaboration with Aviva, the UK's leading diversified insurer.

23 Oct 2025